As of November 6, 2026, COMPASS Pathways plc is a publicly traded company (Nasdaq: CMPS). The largest holder reporting an active stake on Schedule 13D is ATAI Life Sciences N.V., at 6%. No bankruptcy or receivership appears in its SEC Form 8-K filings. Passive holders reporting on Schedule 13G include RTW Investments (9.9%), BIT Capital GmbH (5.9%) (Schedule 13D/A, October 29, 2025).
Is this your company?
About to sign with, pay or invest in COMPASS Pathways plc? See the free Snapshot first.
Free to see. No signup.
Is COMPASS Pathways plc a real, registered company?
- COMPASS Pathways plc files with the SEC under CIK 1816590 (its SEC filings).
- Its shares are listed under the ticker CMPS on Nasdaq (SEC company record).
- Incorporated in X0; business address in Chesire, X0, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under COMPASS Pathways plc in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names BIT Capital GmbH (filed 2026-10-28).
Who are COMPASS Pathways plc's owners and officers?
COMPASS Pathways plc: business address in Chesire, X0; industry Pharmaceutical Preparations (Schedule 13G, 2026-10-28).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2026-10-28 | Bit Capital Gmbh | 5.9% |
| Schedule 13G/A, 2026-05-15 | Rtw Investments, LP | 9.9% |
| Schedule 13D/A, 2026-02-17 | Ataibeckley Inc. | 4.96% |
| Schedule 13G/A, 2025-11-14 | Nantahala Capital Management, LLC | 3.57% |
| Schedule 13G/A, 2025-11-14 | Vivo Opportunity Fund Holdings, L.P. | 3.2% |
| Schedule 13D/A, 2025-10-29 | Atai Life Sciences N.V. | 6% |
| Schedule 13G/A, 2025-08-14 | Chen Yu | 3.9% |
| Schedule 13G/A, 2025-08-14 | Rtw Investments, LP | 9.9% |
| Schedule 13G, 2025-08-14 | Nantahala Capital Management, LLC | 6.23% |
Questions about who owns COMPASS Pathways plc
Who owns COMPASS Pathways plc?
On this page, 3 holders' latest ownership filings report 5% or more of COMPASS Pathways plc: Rtw Investments, LP (9.9%, Schedule 13G/A, filed 2026-05-15), Atai Life Sciences N.V. (6%, Schedule 13D/A, filed 2025-10-29) and Bit Capital Gmbh (5.9%, Schedule 13G, filed 2026-10-28).
Who are the largest shareholders of COMPASS Pathways plc?
By the share each holder's latest filing reports, the largest holders of COMPASS Pathways plc on this page are Rtw Investments, LP (9.9%), Atai Life Sciences N.V. (6%) and Bit Capital Gmbh (5.9%).
When did Rtw Investments, LP buy into COMPASS Pathways plc?
The filings give report dates, not purchase dates. The earliest filing from Rtw Investments, LP on this page is the Schedule 13G/A, filed 2025-08-14, reporting 9.9%; its latest, Schedule 13G/A filed 2026-05-15, reports 9.9%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 9 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on COMPASS Pathways plc?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on COMPASS Pathways plc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on COMPASS Pathways plc covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
14 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own COMPASS Pathways plc shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a 10% owner: 6,307,970 shares (4.5% of shares outstanding), 3,155,122 held directly and 3,152,848 indirectly (Form 4, 2024-10-25).
- , a 10% owner: 6,307,970 shares (4.5% of shares outstanding), 3,152,848 held directly and 3,155,122 indirectly (Form 4, 2024-10-25).
- , the chief executive and a director: 361,028 shares (0.25% of shares outstanding) (Form 4, 2026-08-05).
- , the chief financial officer: 152,002 shares (0.11% of shares outstanding) (Form 4, 2026-03-27).
Shares outstanding: 141,710,353 as of 2026-10-28, from the company's latest SEC cover page.
How much has COMPASS Pathways plc raised?
No fundraising or offering filing from COMPASS Pathways plc is on file with us.
Keep reading
More on COMPASS Pathways plc and the records around it.
COMPASS Pathways plc elsewhere on the record
- 5%+ stake filings Oct 2026
Companies that share a holder
- BIT Capital GmbH also filed stake reports on 1 other company: Freenome, Inc. (Aug 2026)
- TCG Crossover GP I, LLC also filed stake reports on 6 other companies: Abivax SA (Aug 2026), Entrada Therapeutics, Inc. (Aug 2026), Vistagen Therapeutics, Inc. (Aug 2026)
- Vivo Opportunity Fund Holdings, L.P. also filed stake reports on 20 other companies: ArriVent BioPharma, Inc. (Oct 2026), Clene Inc. (Aug 2026), Compass Therapeutics, Inc. (Aug 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/compass-pathways